Prognos Health provides clinical and genomic laboratory data and analytics for pharmaceutical companies.
Founded in 2010 and based in New York, Prognos Health combines laboratory and health records to provide data and analytics for life sciences companies. Its de-identified dataset covers over 325 million patients and supports commercial analytics, real-world evidence and healthcare provider engagement. Destry Sulkes founded the company, and Sundeep Bhan is CEO. In April 2023, it raised USD 23.29 mn in Series I funding, involving Cigna Ventures and Merck Global Health Innovation Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in